J&J Innovative Medicine

Learn about the revolutionary work they’re both doing in the field of neurodegenerative disease that could prove important in fighting often-fatal conditions.

A study of women, by women. We’re talking about the Imbokodo trial, which is evaluating an investigational HIV vaccine in sub-Saharan Africa. As the study hits a key milestone, we sat down with South African physician and scientist Glenda Gray, who’s at the helm of the groundbreaking trial.

Check out this infographic breakdown of the company’s first-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.

The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes.

Check out this infographic breakdown of the company’s annual earnings report, with key performance highlights from its consumer, pharmaceutical and medical devices businesses over the last year.

Pandas and owls and bats, oh my! We’re taking a look at a few of the ways Johnson & Johnson is working to help these and other imperiled species thrive—from the U.S. to the UK.

It’s been 30 years since the first World AIDS Day was recognized. Jens Van Roey, M.D., shares how a fateful diagnosis coincidentally that same year transformed him from a humble physician into a tireless champion for those afflicted with the disease.

Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the third quarter of 2018 in this snapshot of its latest earnings report.

Johnson & Johnson has been instrumental in helping bring us closer to a TB-free world through its groundbreaking work with multidrug-resistant TB.